Human Recellularization for Xenoantigen-Free Decellularized Cardiac Xenografts.

IF 2.9 3区 医学 Q3 CELL & TISSUE ENGINEERING
Ja-Kyoung Yoon, So Young Kim, Serin Kim, Kyung Mee Lee, Sunhi Ko, Gi Beom Kim, Hong-Gook Lim, Yong Jin Kim
{"title":"Human Recellularization for Xenoantigen-Free Decellularized Cardiac Xenografts.","authors":"Ja-Kyoung Yoon, So Young Kim, Serin Kim, Kyung Mee Lee, Sunhi Ko, Gi Beom Kim, Hong-Gook Lim, Yong Jin Kim","doi":"10.1177/19373341251369772","DOIUrl":null,"url":null,"abstract":"<p><p>Removal of major xenoantigens of the Galα1-3Gal (α-Gal) epitope and the nonhuman sialic acid <i>N</i>-glycolylneuraminic acid (Neu5Gc) is essential to eliminate xenoimmunogenicity and optimize recellularization for cardiac xenografts. The aim of this study was to evaluate the safety and efficacy of α-galactosidase for removal of α-Gal xenoantigen and peptide <i>N</i>-glycosidase F (PNGase-F) for removal of non-α-Gal xenoantigen combined with optimal decellularization, and the potential of <i>in vitro</i> recellularization was assessed with coculturing human mesenchymal stem cells and human umbilical vein endothelial cells for major xenoantigen-free cardiac xenografts. We investigated the biomechanical properties and efficacy for xenoantigen removal with expression of carbohydrate-binding lectins in porcine pericardia decellularized and treated with α-galactosidase and PNGase-F. There were no histological changes depending on α-galactosidase and PNGase-F treatment. There was no difference in tensile stress, tensile displacement, tensile strain at break, and permeability test following enzymatic treatments. Both enzyme-treated xenografts were stained with Jacalin, Maackia amurensis lectin I, wheat germ agglutinin, Ricinus communis agglutinin, Griffonia simplicifolia lectin (GSL), erythrina cristagalli lectin, peanut agglutinin, soybean agglutinin, Wisteria floribunda lectin, and Datura stramonium lectin and showed synergistic effects for low fluorescence qualitatively and quantitatively. The enzymatic treatments for decellularization significantly reduced lectin expression, demonstrating the synergistic effect of both enzymes and decellularization. <i>In vitro</i> recellularization for decellularized and both enzymes-treated xenografts was assessed with vimentin, calponin, fibronectin, and CD31 staining. Stronger signals were detected in decellularized xenografts, and decellularized xenografts treated with both enzymes showed significantly faster mesenchymal cell infiltration into the tissue, leading to accelerated recellularization. We have successfully produced major xenoantigen-free scaffolds by demonstrating the safety and the synergistic effect of α-galactosidase and PNGase-F treatments and proved effective recellularization for the xenoantigen-free scaffolds not previously reported in the literature.</p>","PeriodicalId":56375,"journal":{"name":"Tissue Engineering Part A","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue Engineering Part A","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/19373341251369772","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

Removal of major xenoantigens of the Galα1-3Gal (α-Gal) epitope and the nonhuman sialic acid N-glycolylneuraminic acid (Neu5Gc) is essential to eliminate xenoimmunogenicity and optimize recellularization for cardiac xenografts. The aim of this study was to evaluate the safety and efficacy of α-galactosidase for removal of α-Gal xenoantigen and peptide N-glycosidase F (PNGase-F) for removal of non-α-Gal xenoantigen combined with optimal decellularization, and the potential of in vitro recellularization was assessed with coculturing human mesenchymal stem cells and human umbilical vein endothelial cells for major xenoantigen-free cardiac xenografts. We investigated the biomechanical properties and efficacy for xenoantigen removal with expression of carbohydrate-binding lectins in porcine pericardia decellularized and treated with α-galactosidase and PNGase-F. There were no histological changes depending on α-galactosidase and PNGase-F treatment. There was no difference in tensile stress, tensile displacement, tensile strain at break, and permeability test following enzymatic treatments. Both enzyme-treated xenografts were stained with Jacalin, Maackia amurensis lectin I, wheat germ agglutinin, Ricinus communis agglutinin, Griffonia simplicifolia lectin (GSL), erythrina cristagalli lectin, peanut agglutinin, soybean agglutinin, Wisteria floribunda lectin, and Datura stramonium lectin and showed synergistic effects for low fluorescence qualitatively and quantitatively. The enzymatic treatments for decellularization significantly reduced lectin expression, demonstrating the synergistic effect of both enzymes and decellularization. In vitro recellularization for decellularized and both enzymes-treated xenografts was assessed with vimentin, calponin, fibronectin, and CD31 staining. Stronger signals were detected in decellularized xenografts, and decellularized xenografts treated with both enzymes showed significantly faster mesenchymal cell infiltration into the tissue, leading to accelerated recellularization. We have successfully produced major xenoantigen-free scaffolds by demonstrating the safety and the synergistic effect of α-galactosidase and PNGase-F treatments and proved effective recellularization for the xenoantigen-free scaffolds not previously reported in the literature.

无异种抗原脱细胞心脏异种移植物的人细胞再分化。
去除半乳糖α1- 3gal (α-Gal)表位和非人唾液酸n -糖基神经氨酸(Neu5Gc)的主要异种抗原对于消除异种免疫原性和优化心脏异种移植物的再细胞化是必不可少的。本研究的目的是评价α-半乳糖苷酶去除α-半乳糖异种抗原和肽n-糖苷酶F (PNGase-F)去除非α-半乳糖异种抗原联合最佳脱细胞的安全性和有效性,并通过人间充质干细胞和人脐静脉内皮细胞共培养用于无主要异种抗原的心脏异种移植,评估体外再细胞化的潜力。采用α-半乳糖苷酶和PNGase-F对猪心包进行脱细胞处理,研究糖结合凝集素的生物力学特性和去除异种抗原的效果。α-半乳糖苷酶和PNGase-F处理均无组织学改变。酶处理后的拉伸应力、拉伸位移、断裂拉伸应变和渗透性试验均无差异。两种酶处理的异种移植物分别用Jacalin、Maackia amurensis凝集素I、小麦胚芽凝集素、蓖麻凝集素、Griffonia simplicifolia凝集素(GSL)、赤藓(erythrina cristagalli)凝集素、花生凝集素、大豆凝集素、紫藤(Wisteria floribunda)凝集素和曼陀罗(Datura stramonium)凝集素进行染色,定性和定量显示出协同低荧光效应。脱细胞的酶处理显著降低了凝集素的表达,表明酶和脱细胞的协同作用。用vimentin、钙钙蛋白、纤维连接蛋白和CD31染色评估脱细胞和两种酶处理的异种移植物的体外再细胞化。在脱细胞异种移植物中检测到更强的信号,用这两种酶处理的脱细胞异种移植物显示出明显更快的间充质细胞浸润到组织中,导致加速的细胞再化。我们通过证明α-半乳糖苷酶和pnase -f处理的安全性和协同作用,成功制备了主要的无异种抗原支架,并证明了文献中未报道的无异种抗原支架的有效再细胞化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Tissue Engineering Part A
Tissue Engineering Part A Chemical Engineering-Bioengineering
CiteScore
9.20
自引率
2.40%
发文量
163
审稿时长
3 months
期刊介绍: Tissue Engineering is the preeminent, biomedical journal advancing the field with cutting-edge research and applications that repair or regenerate portions or whole tissues. This multidisciplinary journal brings together the principles of engineering and life sciences in the creation of artificial tissues and regenerative medicine. Tissue Engineering is divided into three parts, providing a central forum for groundbreaking scientific research and developments of clinical applications from leading experts in the field that will enable the functional replacement of tissues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信